Trademark: 88205308
Word
IPEC
Status
Dead
Status Code
606
Status Date
Monday, July 11, 2022
Serial Number
88205308
Mark Type
4000
Filing Date
Monday, November 26, 2018
Published for Opposition
Tuesday, October 15, 2019
Abandoned Date
Monday, July 11, 2022

Trademark Owner History
Essenlix Corporation - Owner At Publication

Classifications
5 Biological and chemical testing kits for personal wellness in the nature of diagnostic test kits consisting primarily of medical diagnostic reagents and assays for the detection of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic reagents and assays for testing of body fluids; Medical diagnostic reagents and assays for testing cells, proteins, small molecules, nucleotides, and nucleic acids; Medical diagnostic reagents; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, and genetic diseases; Diagnostic biomarker reagents for medical purposes
1 Assays for research purposes; Biological and chemical reagents used for non-medical research purposes, namely, in vitro and in vivo scientific use, the testing of bodily fluids, and the detecting and analyzing of cells, proteins, small molecules, and nucleotides; chemical test kits for the detection and identification of nucleic acids, namely, DNA and RNA in a sample for laboratory or research use
44 Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing in the nature of diagnostic testing, and wellness counseling services, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of cells, proteins, small molecules, and nucleic acids in a sample for medical purposes
10 Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules, cells, and nucleic acids; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; medical diagnostic devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic instruments, namely, instruments for medical testing in the nature of the detection and identification of nucleic acids, namely, DNA and RNA in a sample

Trademark Events
Jul 11, 2022
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 11, 2022
Abandonment - No Use Statement Filed
Dec 11, 2021
Notice Of Approval Of Extension Request E-Mailed
Dec 9, 2021
Sou Extension 4 Granted
Dec 9, 2021
Sou Extension 4 Filed
Dec 9, 2021
Sou Teas Extension Received
Jun 9, 2021
Notice Of Approval Of Extension Request E-Mailed
Jun 7, 2021
Sou Extension 3 Granted
Jun 7, 2021
Sou Extension 3 Filed
Jun 7, 2021
Sou Teas Extension Received
Nov 27, 2020
Notice Of Approval Of Extension Request E-Mailed
Nov 25, 2020
Sou Extension 2 Granted
Nov 25, 2020
Sou Extension 2 Filed
Nov 25, 2020
Sou Teas Extension Received
Sep 1, 2020
Notice Of Approval Of Extension Request E-Mailed
Aug 31, 2020
Sou Extension 1 Granted
Jun 10, 2020
Sou Extension 1 Filed
Aug 31, 2020
Case Assigned To Intent To Use Paralegal
Jul 10, 2020
Notice Of Revival - E-Mailed
Jul 10, 2020
Sou Extension Received With Teas Petition
Jul 10, 2020
Petition To Revive-Granted
Jul 10, 2020
Teas Petition To Revive Received
Dec 10, 2019
Noa E-Mailed - Sou Required From Applicant
Oct 15, 2019
Official Gazette Publication Confirmation E-Mailed
Oct 15, 2019
Published For Opposition
Sep 25, 2019
Notification Of Notice Of Publication E-Mailed
Sep 12, 2019
Assigned To Lie
Sep 11, 2019
Approved For Pub - Principal Register
Sep 11, 2019
Examiner's Amendment Entered
Sep 11, 2019
Notification Of Examiners Amendment E-Mailed
Sep 11, 2019
Examiners Amendment E-Mailed
Sep 11, 2019
Examiners Amendment -Written
Sep 11, 2019
Notification Of Final Refusal Emailed
Sep 11, 2019
Final Refusal E-Mailed
Sep 11, 2019
Final Refusal Written
Aug 21, 2019
Teas/Email Correspondence Entered
Aug 21, 2019
Correspondence Received In Law Office
Aug 21, 2019
Teas Response To Office Action Received
Feb 27, 2019
Notification Of Non-Final Action E-Mailed
Feb 27, 2019
Non-Final Action E-Mailed
Feb 27, 2019
Non-Final Action Written
Feb 26, 2019
Assigned To Examiner
Dec 13, 2018
New Application Office Supplied Data Entered
Nov 29, 2018
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24